Tim Karhausen
Charité
10 Papers
77 Citations
Tim Karhausen is an academic researcher from Charité. The author has contributed to research in topics: Lean body mass & Cardiac resynchronization therapy. The author has an hindex of 6, co-authored 10 publications.
Chat about Author
Papers
Altered Intestinal Function in Patients With Chronic Heart Failure
Anja Sandek,Juergen Bauditz,Alexander Swidsinski,Sabine Buhner,Jutta Weber-Eibel,Stephan von Haehling,Wieland Schroedl,Tim Karhausen,Wolfram Doehner,Mathias Rauchhaus,Philip A. Poole-Wilson,Hans-Dieter Volk,Herbert Lochs,Stefan D. Anker,Stefan D. Anker +14 more
TL;DR: Chronic heart failure is a multisystem disorder in which intestinal morphology, permeability, and absorption are modified, and increased intestinal permeability and an augmented bacterial biofilm may contribute to the origin of both chronic inflammation and malnutrition.
600
Exercise capacity and body composition in living-donor renal transplant recipients over time
Dirk Habedank,Thomas Kung,Tim Karhausen,Stephan von Haehling,Wolfram Doehner,Joerg C. Schefold,Dietrich Hasper,Simon Reinke,Stefan D. Anker,Petra Reinke +9 more
TL;DR: After Renal transplantation (RTx), body composition shifted continuously towards fat tissue, and baseline lean weight significantly correlated with fat increase over time, and exercise capacity worsened after RTx and restitutes during follow-up, with muscle quality even exceeding baseline levels after 12 months.
39
Electrical Remodeling and Cardiac Dimensions in Patients Treated by Cardiac Resynchronization and Heart Failure Controls
Martin Stockburger,Aischa Nitardy,Suzanne Fateh-Moghadam,Alice Krebs,Özlem Celebi,Tim Karhausen,Rainer Dietz +6 more
TL;DR: Cardiac resynchronization therapy (CRT) reduces the left ventricular diameter (LVEDD) in heart failure patients with left bundle branch block and matched HF controls without LBBB are compared.
31
Vasodilation and Exercise Capacity in Patients with End-Stage Renal Disease: A Prospective Proof-of-Concept Study
Dirk Habedank,Joerg C. Schefold,Carolin Bernhardt,Tim Karhausen,Wolfram Doehner,Stefan D. Anker,Petra Reinke +6 more
TL;DR: In this proof-of-concept study, exercise capacity was relatively preserved, while vasodilative capacity was substantially impaired in ESRD patients.
Anemia in chronic heart failure--clinical and prognostic significance.
TL;DR: The option of therapeutically targeting anemia in CHF is an intriguing novel approach to improve morbidity and potentially mortality in patients with CHF.
6